MQS Management’s Core Laboratories CLB Stock Holding History

MQS Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,937	Closed	-$160K	–	448
2025 Q3	$160K	Buy	+12,937	New	+$152K	0.09%	385

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MQS Management's CLB Position: Q4 2025 in Review

MQS Management sold out of Core Laboratories (CLB) in Q4 2025, closing a stake of 12,937 shares — an estimated $160K sold.

MQS Management first reported a position in CLB in Q3 2025 and held it in 1 quarter. The position peaked at $160K in Q3 2025. 187 funds tracked by Wall St. Rank hold CLB as of Q4 2025.

MQS Management reported no remaining Core Laboratories position as of Q4 2025 after selling out during the quarter.
MQS Management sold 12,937 Core Laboratories shares in Q4 2025, an estimated $160K.
MQS Management first reported a position in Core Laboratories in Q3 2025 and held it in 1 quarter.
MQS Management's Core Laboratories position peaked at $160K in Q3 2025.
187 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2025.

Based on MQS Management's 13F filing for Q4 2025, filed 9 Feb 2026.